Published in Neurobiol Aging on November 27, 2006
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry (2010) 2.22
Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry (2005) 1.63
Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging (2005) 1.46
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial. Phys Ther (2009) 1.35
From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol (2012) 1.33
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev (2010) 1.30
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis (2010) 1.23
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Immunotherapy (2012) 1.18
The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J Alzheimers Dis (2009) 1.16
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry (2012) 1.08
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. J Alzheimers Dis (2010) 1.06
Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp Gerontol (2005) 1.06
Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother (2008) 1.06
Marital and cohabitation status as predictors of mortality: a 10-year follow-up of an Italian elderly cohort. Soc Sci Med (2008) 1.05
Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option? Expert Opin Investig Drugs (2011) 1.04
Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta (2005) 1.03
Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging (2009) 1.02
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging (2011) 1.00
Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev (2008) 1.00
Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiol Aging (2005) 0.99
Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment? Front Aging Neurosci (2010) 0.98
Lipid metabolism in cognitive decline and dementia. Brain Res Rev (2006) 0.98
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease. Ageing Res Rev (2009) 0.98
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes. J Alzheimers Dis (2009) 0.98
Solanezumab for the treatment of mild-to-moderate Alzheimer's disease. Expert Rev Clin Immunol (2012) 0.97
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy. J Gerontol A Biol Sci Med Sci (2006) 0.97
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. Expert Rev Neurother (2014) 0.97
Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging. Dement Geriatr Cogn Disord (2008) 0.96
Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging (2009) 0.96
Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis (2010) 0.96
Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging. J Alzheimers Dis (2009) 0.96
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease? Curr Opin Psychiatry (2014) 0.96
REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current state. CNS Neurosci Ther (2010) 0.96
Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. Int J Geriatr Psychiatry (2008) 0.95
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. Expert Rev Clin Immunol (2014) 0.93
Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab. Curr Alzheimer Res (2011) 0.93
Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry (2009) 0.93
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia. J Rehabil Med (2009) 0.93
Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return? Expert Opin Biol Ther (2014) 0.93
The Caregiver Burden Inventory in evaluating the burden of caregivers of elderly demented patients: results from a multicenter study. Aging Clin Exp Res (2005) 0.92
Mediterranean diet, mild cognitive impairment, and Alzheimer's disease. Exp Gerontol (2006) 0.92